Systematic Analysis of the Multiple Bioactivities of Green Tea through a Network Pharmacology Approach

Table 2

Diseases affected by GTPs and related pathways.

Disease	Related pathway
Cancer	Glioma (hsa05214)^a
	Pathways in cancer (hsa05200)^a
	Prostate cancer (hsa05215)^a
	Non-small-cell lung cancer (hsa05223)^a
	Melanoma (hsa05218)^a
	Pancreatic cancer (hsa05212)^a
	Endometrial cancer (hsa05213)^a
	Bladder cancer (hsa05219)^a
	Small cell lung cancer (hsa05222)^a
	Acute myeloid leukemia (hsa05221)^a
	Colorectal cancer (hsa05210)^a
	Renal cell carcinoma (hsa05211)^a
Diabetic	p53 signaling pathway (hsa04115)^a
	Type II diabetes mellitus (hsa04930)^b
Neurodegenerative; disease	Fc epsilon RI signaling pathway (hsa04664)^a
	Fc gamma R-mediated phagocytosis (hsa04666)^a
	Alzheimer’s disease (hsa05010)^b
Cardiovascular diseases	Vascular smooth muscle contraction (hsa04270)^b
Muscular disease	Chemokine signaling pathway (hsa04062)^b
Inflammation	B cell receptor signaling pathway (hsa04662)^a

value < 0.05; ^b value > 0.05.